Cargando…
Long‐Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study
BACKGROUND: Carvedilol may have favorable glycemic properties compared with metoprolol, but it is unknown if carvedilol has mortality benefit over metoprolol in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: Using Danish nationwide...
Autores principales: | Schwartz, Brian, Pierce, Colin, Madelaire, Christian, Schou, Morten, Kristensen, Søren Lund, Gislason, Gunnar H., Køber, Lars, Torp‐Pedersen, Christian, Andersson, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649547/ https://www.ncbi.nlm.nih.gov/pubmed/34533058 http://dx.doi.org/10.1161/JAHA.121.021310 |
Ejemplares similares
-
Identification of Patients with New-Onset Heart Failure and Reduced Ejection Fraction in Danish Administrative Registers
por: Madelaire, Christian, et al.
Publicado: (2020) -
Rate of Heart Failure Following Atrial Fibrillation According to Presence of Family History of Dilated Cardiomyopathy or Heart Failure: A Nationwide Study
por: Ebbesen, Magnus N., et al.
Publicado: (2021) -
Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study
por: Schwartz, Brian, et al.
Publicado: (2022) -
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007) -
Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study
por: Thein, David, et al.
Publicado: (2020)